Difan Shen - Alibaba Health CEO, Executive Director
| ALBHF Stock | USD 0.46 0.02 4.17% |
CEO
Mr. Shen Difan is Chief Executive Officer, Executive Director of the Company. He was appointed as the executive Director and chief executive officer of the Company on March 29, 2018. Prior to his current position, he was the general manager of Alibaba Groups AliExpress business from March 2012, and led the rapid expansion of AliExpress, growing Alibaba Groups overseas brand influence. Mr. Shen joined Alibaba Group in 2004 and had held various positions in Alibaba Group, including in relation to B2B product operations, and in the security department and advertising product department. Mr. Shen holds a bachelors degree in computing from Yantai University since 2018.
| Age | 44 |
| Tenure | 6 years |
| Phone | 852 2583 9333 |
| Web | https://www.alihealth.cn |
Alibaba Health Management Efficiency
The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. Alibaba Health's management efficiency ratios could be used to measure how well Alibaba Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | CEO Age | ||
| Sandra Campos | PetMed Express | 57 | |
| Timothy Wentworth | Walgreens Boots Alliance | 64 | |
| Mathew Hulett | PetMed Express | 53 | |
Management Performance
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 |
Alibaba Health Infor Leadership Team
Elected by the shareholders, the Alibaba Health's board of directors comprises two types of representatives: Alibaba Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alibaba. The board's role is to monitor Alibaba Health's management team and ensure that shareholders' interests are well served. Alibaba Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alibaba Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yanwu Tu, CFO Director | ||
| Ka Chun, Company Sec | ||
| Shunyan Zhu, Chairman CEO | ||
| Difan Shen, CEO, Executive Director | ||
| Chun Kwong, Financial Controller | ||
| Chun Yan, Company Sec |
Alibaba Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Alibaba Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 14.83 B | |||
| Shares Outstanding | 13.52 B | |||
| Shares Owned By Insiders | 64.61 % | |||
| Shares Owned By Institutions | 10.90 % | |||
| Price To Earning | 232.77 X | |||
| Price To Book | 7.69 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Alibaba Pink Sheet
Alibaba Health financial ratios help investors to determine whether Alibaba Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alibaba with respect to the benefits of owning Alibaba Health security.